Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Lexicon Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- −11 vs. Q2 2021
- Shares held
- 121.2M
- +3.50M (+3.0%) vs. Q2 2021
- Total value
- $583.0M
- +$42.8M (+7.9%) vs. Q2 2021
- New holders
- 8
- 33 more added
- Sold out
- 19
- 35 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 149 | $875.1M |
| Q1 2026 | 137 | $504.5M |
| Q4 2025 | 126 | $299.5M |
| Q3 2025 | 124 | $344.4M |
| Q2 2025 | 123 | $242.9M |
| Q1 2025 | 127 | $122.5M |
| Q4 2024 | 127 | $220.1M |
| Q3 2024 | 137 | $453.1M |
| Q2 2024 | 127 | $471.0M |
| Q1 2024 | 118 | $417.8M |
| Q4 2023 | 106 | $279.8M |
| Q3 2023 | 112 | $205.8M |
| Q2 2023 | 123 | $438.2M |
| Q1 2023 | 104 | $353.8M |
| Q4 2022 | 105 | $280.5M |
| Q3 2022 | 98 | $357.3M |
| Q2 2022 | 86 | $221.0M |
| Q1 2022 | 101 | $251.3M |
| Q4 2021 | 110 | $478.9M |
| Q3 2021 | 96 | $583.0M |
| Q2 2021 | 107 | $540.2M |
| Q1 2021 | 107 | $711.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lexicon Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AXA S.A. | 0 | $0 | 0.00% | −285,500−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −151,659−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −59,775−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −54,333−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −33,333−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −31,408−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −21,505−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −21,454−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −17,612−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −280−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1−100.0% | Sold out |